Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.390,15
-1,46%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tempest Therpeutics Inc (TPST) Tempest Therpeutics Inc (TPST) Notizie

Tempest Therpeutics Inc

TPST
3,70
0,23 (6,63%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/4/202422:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
09/4/202414:00GLOBETempest Reports New Preclinical Data for TPST-1120 in RCC at..
04/4/202414:00GLOBETempest Announces Publication of Positive Data from Phase 1..
19/3/202421:25GLOBETempest Reports Year End 2023 Financial Results and Provides..
12/3/202413:00GLOBETempest Presents New Data at the SITC 2024 Spring Scientific..
05/3/202422:30GLOBETempest Announces Upcoming Presentation of Preclinical Data..
26/2/202414:00GLOBETempest to Present at the 44th Annual TD Cowen Healthcare..
15/2/202400:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202420:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:41EDGAR2Form SC 13D/A - General statement of acquisition of..
02/2/202422:30GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
05/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
01/12/202322:15GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
20/11/202314:00GLOBETempest to Present at the 35th Annual Piper Sandler..
17/11/202322:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:43EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202323:28EDGAR2Form SC 13D/A - General statement of acquisition of..
08/11/202323:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202323:18EDGAR2Form 8-K - Current report
08/11/202323:17GLOBETempest Reports Third Quarter 2023 Financial Results and..
02/11/202321:16EDGAR2Form 144 - Report of proposed sale of securities
30/10/202311:06EDGAR2Form 8-K - Current report
13/10/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202312:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202314:29EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
11/10/202314:13EDGAR2Form 8-K - Current report
11/10/202314:01GLOBETempest Adopts Limited Duration Stockholder Rights Plan
11/10/202314:00GLOBETempest Releases New Data Demonstrating Superiority of..
10/10/202322:05GLOBETempest to Report New and Updated Data from Global..
19/9/202314:00GLOBETempest Announces Expanded Role for Sam Whiting, M.D.,..
08/9/202322:16EDGAR2Form 8-K - Current report
07/9/202322:19EDGAR2Form 8-K - Current report
05/9/202314:00GLOBETempest to Present at the H.C. Wainwright 25th Annual Global..
10/8/202322:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:27EDGAR2Form 8-K - Current report
10/8/202322:13GLOBETempest Reports Second Quarter 2023 Financial Results and..
19/7/202314:00GLOBETempest Announces Publication in Cancer Research..
31/5/202322:05GLOBETempest to Present at the Jefferies Global Healthcare..
25/5/202323:00GLOBETempest to Present Phase 1 Monotherapy and Combination Data..
Apertura: 3,47 Min: 3,4201 Max: 3,67
Chiusura: 3,47

La tua Cronologia

NASDAQ
TPST
Tempest Therpeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network